MHR
ABBV icon

Matthew Hamilton Rosenberg’s AbbVie ABBV Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
4,135
+141
+4% +$30.3K 0.19% 57
2026
Q1 		$869K Buy
3,994
+116
+3% +$25.7K 0.18% 60
2025
Q4 		$886K Sell
3,878
-11
-0.3% -$2.51K 0.18% 56
2025
Q3 		$901K Hold
3,889
– – 0.19% 55
2025
Q2 		$722K Buy
3,889
+450
+13% +$83.6K 0.17% 58
2025
Q1 		$721K Buy
3,439
+278
+9% +$54K 0.18% 55
2024
Q4 		$562K Buy
3,161
+174
+6% +$32K 0.15% 67
2024
Q3 		$590K Buy
2,987
+37
+1% +$6.91K 0.15% 69
2024
Q2 		$503K Sell
2,950
-455
-13% -$75.4K 0.15% 71
2024
Q1 		$615K Buy
3,405
+30
+0.9% +$5.17K 0.18% 61
2023
Q4 		$523K Buy
3,375
+81
+2% +$11.8K 0.16% 66
2023
Q3 		$491K Sell
3,294
-88
-3% -$12.9K 0.16% 63
2023
Q2 		$456K Sell
3,382
-749
-18% -$110K 0.15% 69
2023
Q1 		$658K Sell
4,131
-92
-2% -$14.1K 0.21% 56
2022
Q4 		$683K Buy
4,223
+100
+2% +$15.3K 0.23% 55
2022
Q3 		$553K Buy
4,123
+240
+6% +$34.4K 0.21% 58
2022
Q2 		$597K Buy
3,883
+301
+8% +$46K 0.23% 61
2022
Q1 		$581K Buy
3,582
+261
+8% +$37.9K 0.2% 63
2021
Q4 		$450K Buy
3,321
+250
+8% +$29.5K 0.16% 73
2021
Q3 		$331K Buy
3,071
+787
+34% +$89.9K 0.13% 99
2021
Q2 		$257K Hold
2,284
– – 0.13% 99
2021
Q1 		$247K Hold
2,284
– – 0.14% 94
2020
Q4 		$245K Sell
2,284
-93
-4% -$8.94K 0.15% 82
2020
Q3 		$208K Hold
2,377
– – 0.15% 86
2020
Q2 		$233K Buy
2,377
+547
+30% +$48.2K 0.19% 70
2020
Q1 		$140K Buy
+1,830
New +$156K 0.14% 86

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Matthew Hamilton Rosenberg's ABBV Position: Q2 2026 in Review

Matthew Hamilton Rosenberg increased its AbbVie (ABBV) stake by 3.5% in Q2 2026, buying an estimated $30.3K and bringing the position to 4,135 shares worth $1.04M. The position accounts for 0.19% of the portfolio, ranked #57.

Matthew Hamilton Rosenberg first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Matthew Hamilton Rosenberg held 4,135 shares of AbbVie worth $1.04M as of Q2 2026.
  • Matthew Hamilton Rosenberg bought 141 AbbVie shares in Q2 2026, an estimated $30.3K.
  • AbbVie made up 0.19% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #57 holding.
  • Matthew Hamilton Rosenberg first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.